| Active ingredient (INN) | Gemfibrozil |
|---|---|
| Brand names | Lopid |
| Therapeutic category | Auto-created by U.S. Food and Drug Administration — Drug Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | TILLOMED LABORATORIES LIMITED, Alphapharm Pty Ltd, Medis Pharma Pty Ltd, NCS HealthCare of KY, LLC dba Vangard Labs |
| Registrations on file | 7 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| GEMFIBROZIL 600MG FILM-COATED TABLETS | 600MG | tablet | 🇬🇧 GB | TILLOMED LABORATORIES LIMITED | Active |
| LIPIGEM gemfibrozil | 600mg | — | 🇦🇺 AU | Alphapharm Pty Ltd | Active |
| AUSGEM gemfibrozil | 600mg | — | 🇦🇺 AU | — | Active |
| Pharmacor Gemfibrozil | 600 g | tabfc | 🇦🇺 AU | — | Active |
| GEMFITRIL gemfibrozil | 600mg | tabfc | 🇦🇺 AU | — | Active |
| As | 600mg | tabfc | 🇦🇺 AU | Medis Pharma Pty Ltd | Active |
| Gemfibrozil | 600mg/1 | tablet | 🇺🇸 US | NCS HealthCare of KY, LLC dba Vangard Labs | Active |